MACE Increased in High-Risk Patients After Noncardiac Surgery
About 20 percent of high-risk patients undergoing noncardiac surgery will develop one or more major adverse cardiovascular events (MACE) within one year.
Surgery
Bariatric Surgery Reduces Need for Antihypertensive Medications at 3 Years
Patients who undergo RYGB are less likely to need antihypertensive medications at 3 years compared with those who manage their blood pressure with medical therapy alone.
AHA Details How to Lower Stroke Risk During, After Heart Surgery
Recommendations are presented for reducing the risk for perioperative stroke in adults undergoing cardiac and thoracic aortic operations.
Reviewing Cardiovascular Risk Assessment, Perioperative Management for Noncardiac Surgery
Researchers identified evidence trough a literature review for risk assessment, testing, and optimal medical therapy to reduce perioperative cardiovascular risk prior to noncardiac surgery.
Reoperative Cardiac Surgery May Predict Short- and Long-Term Mortality
Reoperative cardiac surgery was found to predict short- and long-term mortality.
Five-Year Outcomes Comparable for TAVR, Surgical AVR
There is no significant difference in the incidence of death or disabling stroke at five years among patients with aortic stenosis at intermediate surgical risk who undergo transcatheter aortic valve replacement or surgical aortic valve replacement.
Comparable Outcomes With Short Stay After Open Heart Surgery
Shorter length of stay after elective cardiac surgery with cardiopulmonary bypass does not result in worse outcomes or increased readmission rates.
Biomarker May Predict Cardiac Risk in Noncardiac Surgery
Preoperative levels of NT-proBNP may be useful for improving preoperative cardiac risk stratification
Postoperative Infection With Risk for Long-Term Infection and Mortality
Data published in JAMA Surgery showed that patients with 30-day postoperative infection had a 3.2-fold higher risk for 1-year infection and a 1.9-fold higher risk for mortality compared with those with no infections.
Self-Expanding Transcatheter Aortic Heart Valve May Be Safe
Implantation of the self-expanding Biovalve transcatheter heart valve for the treatment of severe aortic stenosis was deemed to be safe, with clinical outcomes similar to those of other first-generation devices designed for the same indication.
-
Loading...
-
Loading...
Next post in Vascular Medicine
